SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 36 filers reported holding SCPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $738,000 | -52.5% | 246,057 | -40.5% | 0.14% | -57.1% |
| Q4 2018 | $1,555,000 | -43.6% | 413,504 | -12.0% | 0.34% | -25.9% |
| Q3 2018 | $2,758,000 | +20.1% | 469,799 | +15.8% | 0.46% | +19.1% |
| Q2 2018 | $2,297,000 | -13.2% | 405,807 | +90.2% | 0.38% | -24.9% |
| Q1 2018 | $2,645,000 | +32.5% | 213,317 | +29.2% | 0.51% | +31.8% |
| Q4 2017 | $1,996,000 | – | 165,100 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |